Keywords
Last Name
Institution

SHREYASKUMAR PATEL

TitleProfessor
InstitutionMD Anderson
DepartmentSarcoma Medical Oncology
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Wagner MJ, Livingston JA, Patel SR, Benjamin RS. Chemotherapy for Bone Sarcoma in Adults. J Oncol Pract. 2016 Mar; 12(3):208-16. PMID: 26962160.
      View in: PubMed
    2. Etchebehere EC, Hobbs BP, Milton DR, Malawi O, Patel S, Benjamin RS, Macapinlac HA. Assessing the role of (18)F-FDG PET and (18)F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2016 May; 43(5):860-70. PMID: 26631240.
      View in: PubMed
    3. Joseph J, Wang WL, Patnana M, Ramesh N, Benjamin R, Patel S, Ravi V. Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma. Clin Sarcoma Res. 2015; 5:22. PMID: 26500758.
      View in: PubMed
    4. Fan Z, Patel S, Lewis VO, Guadagnolo BA, Lin PP. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas? Clin Orthop Relat Res. 2015 Nov; 473(11):3604-11. PMID: 26197952.
      View in: PubMed
    5. Tseng WW, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PW. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67. PMID: 26177983.
      View in: PubMed
    6. Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Mayfield J, Miller VA, Stephens PJ, Ross JS, Ali SM. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol. 2015; 8:66. PMID: 26062823.
      View in: PubMed
    7. Goldschlager T, Dea N, Boyd M, Reynolds J, Patel S, Rhines LD, Mendel E, Pacheco M, Ramos E, Mattei TA, Fisher CG. Giant cell tumors of the spine: has denosumab changed the treatment paradigm? J Neurosurg Spine. 2015 May; 22(5):526-33. PMID: 25700239.
      View in: PubMed
    8. Benjamin RS, Wagner MJ, Livingston JA, Ravi V, Patel SR. Chemotherapy for bone sarcomas in adults: the MD anderson experience. Am Soc Clin Oncol Educ Book. 2015; e656-60. PMID: 25993237.
      View in: PubMed
    9. Ravi V, Patel S, Benjamin RS. Chemotherapy for soft-tissue sarcomas. Oncology (Williston Park). 2015 Jan; 29(1):43-50. PMID: 25592207.
      View in: PubMed
    10. Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Delannes M, Litière S, Bonnetain F, Dabakuyo TS, Benjamin RS, Blay JY, Bui BN, Collin F, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Italiano A, Jooste V, Krarup-Hansen A, Le Péchoux C, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Ray-Coquard I, Rutkowski P, Schuetze S, Sleijfer S, Stoeckle E, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Mathoulin-Pélissier S. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. Ann Oncol. 2015 May; 26(5):865-72. PMID: 25070543.
      View in: PubMed
    11. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL, Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma. 2014; 2014:375151. PMID: 25024639.
      View in: PubMed
    12. Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, Arfi-Roufe J, Berdelou A, Moon B, Al Ghuzlan A, Patel S, Leboulleux S, Jimenez C. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. Eur J Endocrinol. 2014 Sep; 171(3):R111-22. PMID: 24891137.
      View in: PubMed
    13. Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, Trent J, Savage SA, Mirabello L, Reinke D, Barkaukas DA, Krailo M, Bernstein M. Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res. 2014 Aug 15; 20(16):4200-9. PMID: 24803583.
      View in: PubMed
    14. Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PW, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014 May 20; 32(15):1563-70. PMID: 24638003; PMCID: PMC4026579.
    15. Blay JY, Leahy MG, Nguyen BB, Patel SR, Hohenberger P, Santoro A, Staddon AP, Penel N, Piperno-Neumann S, Hendifar A, Lardelli P, Nieto A, Alfaro V, Chawla SP. Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas. Eur J Cancer. 2014 Apr; 50(6):1137-47. PMID: 24512981.
      View in: PubMed
    16. Patel SR. Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy. Am Soc Clin Oncol Educ Book. 2014; 259-62. PMID: 24857084.
      View in: PubMed
    17. Ganjoo KN, Patel S. The treatment outcome for adult patients with Ewing's sarcoma. Curr Oncol Rep. 2013 Aug; 15(4):372-7. PMID: 23605781.
      View in: PubMed
    18. Ravi V, Patel S. Vascular sarcomas. Curr Oncol Rep. 2013 Aug; 15(4):347-55. PMID: 23852636.
      View in: PubMed
    19. Patel S. Exploring novel therapeutic targets in GIST: focus on the PI3K/Akt/mTOR pathway. Curr Oncol Rep. 2013 Aug; 15(4):386-95. PMID: 23605780.
      View in: PubMed
    20. Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med. 2013 Aug; 2(4):553-63. PMID: 24156028.
      View in: PubMed
    21. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res. 2013; 3(1):7. PMID: 23663788.
      View in: PubMed
    22. Yadav BS, Bansal A, Sharma SC, Javid SH, Anderson BO, Vaklavas C, Forero A, Ravi V, Patel S, Boudadi K, Chugh R, Morris GJ. A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer. Semin Oncol. 2013 Apr; 40(2):135-44. PMID: 23540738.
      View in: PubMed
    23. Patel S. Long-term efficacy of imatinib for treatment of metastatic GIST. Cancer Chemother Pharmacol. 2013 Aug; 72(2):277-86. PMID: 23503753.
      View in: PubMed
    24. Samuels BL, Chawla S, Patel S, von Mehren M, Hamm J, Kaiser PE, Schuetze S, Li J, Aymes A, Demetri GD. Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study. Ann Oncol. 2013 Jun; 24(6):1703-9. PMID: 23385197.
      View in: PubMed
    25. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res. 2012; 2(1):25. PMID: 23272660.
      View in: PubMed
    26. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S. Prognostic significance of elevated D-dimer for survival in patients with sarcoma. Am J Clin Oncol. 2012 Oct; 35(5):462-7. PMID: 21654313.
      View in: PubMed
    27. Richey SL, Rao P, Wood CG, Patel S, Tannir NM. Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy. Clin Genitourin Cancer. 2012 Sep; 10(3):210-2. PMID: 22503609; PMCID: PMC4121061.
    28. Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. Oncologist. 2012; 17(3):321. PMID: 22363068.
      View in: PubMed
    29. Ravi V, Patel S. Adjuvant chemotherapy for soft tissue sarcomas. Surg Oncol Clin N Am. 2012 Apr; 21(2):243-53. PMID: 22365517.
      View in: PubMed
    30. Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Randall RL, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS. Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother. 2012 Jul; 61(7):1113-24. PMID: 22198309; PMCID: PMC3378844.
    31. Patel S. Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance. Cancer Treat Rev. 2012 Aug; 38(5):467-72. PMID: 22035971.
      View in: PubMed
    32. Pappo AS, Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH. R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. J Clin Oncol. 2011 Dec 1; 29(34):4541-7. PMID: 22025149; PMCID: PMC3236654.
    33. Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 1; 118(11):2804-12. PMID: 22006217; PMCID: PMC3882190.
    34. Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, Bilsky MH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fisher CG. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol. 2011 Aug 1; 29(22):3072-7. PMID: 21709187.
      View in: PubMed
    35. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011 Nov 1; 117(21):4939-47. PMID: 21480200; PMCID: PMC3135685.
    36. Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1142-6. PMID: 21394894; PMCID: PMC3134599.
    37. Clark DW, Moore BA, Patel SR, Guadagnolo BA, Roberts DB, Sturgis EM. Malignant fibrous histiocytoma of the head and neck region. Head Neck. 2011 Mar; 33(3):303-8. PMID: 20629084.
      View in: PubMed
    38. Ganjoo KN, Patel S. Current and emerging pharmacological treatments for gastrointestinal stromal tumour. Drugs. 2011 Feb 12; 71(3):321-30. PMID: 21319869.
      View in: PubMed
    39. Patel S. Navigating risk stratification systems for the management of patients with GIST. Ann Surg Oncol. 2011 Jun; 18(6):1698-704. PMID: 21213058.
      View in: PubMed
    40. Huh WW, Guadagnolo BA, Munsell MF, Patel S, Lewis VO. Soft tissue sarcomas of the popliteal fossa: a single-institution retrospective review. Cancer. 2011 Jun 15; 117(12):2728-34. PMID: 21656751.
      View in: PubMed
    41. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25. PMID: 21190975.
      View in: PubMed
    42. Patel SR. Gastrointestinal Stromal Tumors (GIST) special issue. Preface. Cancer Chemother Pharmacol. 2011 Jan; 67 Suppl 1:S1. PMID: 21116629.
      View in: PubMed
    43. Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010 Oct 15; 35(22):E1221-9. PMID: 20562730.
      View in: PubMed
    44. Pisters PW, Patel SR. Gastrointestinal stromal tumors: current management. J Surg Oncol. 2010 Oct 1; 102(5):530-8. PMID: 20063363.
      View in: PubMed
    45. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010 Sep 21; 153(6):358-67. PMID: 20855800.
      View in: PubMed
    46. Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, Benjamin RS, Baker LH. Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res. 2010 Oct 1; 16(19):4884-91. PMID: 20724445.
      View in: PubMed
    47. Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K, Renard M, Sciot R, Rao P, Oberlin O, Delattre O, Shipley J. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer. 2010 Jun 8; 102(12):1769-77. PMID: 20502458; PMCID: PMC2883695.
    48. Pandurengan RK, Dumont AG, Araujo DM, Ludwig JA, Ravi V, Patel S, Garber J, Benjamin RS, Strom SS, Trent JC. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol. 2010 Oct; 21(10):2107-11. PMID: 20348145.
      View in: PubMed
    49. Trent JC, Patel SS, Zhang J, Araujo DM, Plana JC, Lenihan DJ, Fan D, Patel SR, Benjamin RS, Khakoo AY. Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate. Cancer. 2010 Jan 1; 116(1):184-92. PMID: 19885836; PMCID: PMC4306337.
    50. Ganjoo KN, Demetri GD, Jacobs C, Patel S. Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec. Leuk Lymphoma. 2009 Nov; 50(11):1882-4. PMID: 19883316.
      View in: PubMed
    51. Ganjoo KN, Patel SR. Trabectedin: an anticancer drug from the sea. Expert Opin Pharmacother. 2009 Nov; 10(16):2735-43. PMID: 19743937.
      View in: PubMed
    52. Yamazaki T, McLoughlin GS, Patel S, Rhines LD, Fourney DR. Feasibility and safety of en bloc resection for primary spine tumors: a systematic review by the Spine Oncology Study Group. Spine (Phila Pa 1976). 2009 Oct 15; 34(22 Suppl):S31-8. PMID: 19829275.
      View in: PubMed
    53. Schuetze SM, Patel S. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Oncologist. 2009 Oct; 14(10):1003-12. PMID: 19808770.
      View in: PubMed
    54. Gupta GR, Yasko AW, Lewis VO, Cannon CP, Raymond AK, Patel S, Lin PP. Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer. 2009 Aug 15; 115(16):3767-73. PMID: 19517468.
      View in: PubMed
    55. Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, del Muro XG. Sarcomas with spindle cell morphology. Semin Oncol. 2009 Aug; 36(4):324-37. PMID: 19664493.
      View in: PubMed
    56. Chugh R, Wathen JK, Maki RG, Benjamin RS, Patel SR, Meyers PA, Myers PA, Priebat DA, Reinke DK, Thomas DG, Keohan ML, Samuels BL, Baker LH. Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model. J Clin Oncol. 2009 Jul 1; 27(19):3148-53. PMID: 19451433.
      View in: PubMed
    57. Rolston KV, Frisbee-Hume SE, Patel S, Manzullo EF, Benjamin RS. Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients. Support Care Cancer. 2010 Jan; 18(1):89-94. PMID: 19387695.
      View in: PubMed
    58. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Mar 28; 373(9669):1097-104. PMID: 19303137.
      View in: PubMed
    59. Trent JC, Patel SR. Clinical update on adult and pediatric gastrointestinal stromal tumor. Preface. Hematol Oncol Clin North Am. 2009 Feb; 23(1):xiii-xiv. PMID: 19248966.
      View in: PubMed
    60. Benjamin RS, Patel SR. Pediatric and adult osteosarcoma: comparisons and contrasts in presentation and therapy. Cancer Treat Res. 2009; 152:355-63. PMID: 20213401.
      View in: PubMed
    61. Davis EC, Ballo MT, Luna MA, Patel SR, Roberts DB, Nong X, Sturgis EM. Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience. Head Neck. 2009 Jan; 31(1):28-36. PMID: 18767171.
      View in: PubMed
    62. Rao G, Suki D, Chakrabarti I, Feiz-Erfan I, Mody MG, McCutcheon IE, Gokaslan Z, Patel S, Rhines LD. Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine. 2008 Aug; 9(2):120-8. PMID: 18764743.
      View in: PubMed
    63. Patel S, Zalcberg JR. Optimizing the dose of imatinib for treatment of gastrointestinal stromal tumours: lessons from the phase 3 trials. Eur J Cancer. 2008 Mar; 44(4):501-9. PMID: 18234488.
      View in: PubMed
    64. Kopp HG, Patel S, Brücher B, Hartmann JT. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma. Am J Clin Dermatol. 2008; 9(4):207-17. PMID: 18572972.
      View in: PubMed
    65. Armistead PM, Salganick J, Roh JS, Steinert DM, Patel S, Munsell M, El-Naggar AK, Benjamin RS, Zhang W, Trent JC. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer. 2007 Nov 15; 110(10):2293-303. PMID: 17896786.
      View in: PubMed
    66. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Benjamin RS, Pollock RE. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):760-5. PMID: 17892916.
      View in: PubMed
    67. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PW, Benjamin RS, Pollock RE. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1173-80. PMID: 17689031.
      View in: PubMed
    68. Harb WJ, Luna MA, Patel SR, Ballo MT, Roberts DB, Sturgis EM. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension. Head Neck. 2007 Aug; 29(8):731-40. PMID: 17274049.
      View in: PubMed
    69. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007 Jul 1; 25(19):2755-63. PMID: 17602081.
      View in: PubMed
    70. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We should desist using RECIST, at least in GIST. J Clin Oncol. 2007 May 1; 25(13):1760-4. PMID: 17470866.
      View in: PubMed
    71. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007 May 1; 25(13):1785-91. PMID: 17470870.
      View in: PubMed
    72. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007 May 1; 25(13):1753-9. PMID: 17470865.
      View in: PubMed
    73. Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, Patel SR, Madewell JE, Lewis VO, Cannon CP, Benjamin RS, Yasko AW. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer. 2007 Feb 1; 109(3):603-11. PMID: 17177205.
      View in: PubMed
    74. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007 Jan; 14(1):14-24. PMID: 17072676.
      View in: PubMed
    75. Patel S, Keohan ML, Saif MW, Rushing D, Baez L, Feit K, DeJager R, Anderson S. Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy. Cancer. 2006 Dec 15; 107(12):2881-7. PMID: 17109446.
      View in: PubMed
    76. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):158-63. PMID: 17084545.
      View in: PubMed
    77. Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Cancer. 2006 Nov 1; 107(9):2237-44. PMID: 16998931.
      View in: PubMed
    78. Rolston KV, Manzullo EF, Elting LS, Frisbee-Hume SE, McMahon L, Theriault RL, Patel S, Benjamin RS. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules. Cancer. 2006 Jun 1; 106(11):2489-94. PMID: 16628654.
      View in: PubMed
    79. Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, Burgess M, Patel S, Pollock RE, Cormier JN. Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8. PMID: 16288486.
      View in: PubMed
    80. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol. 2006 Jan 1; 24(1):11-2. PMID: 16330666.
      View in: PubMed
    81. Hartmann JT, Patel S. New drug developments for patients with metastatic soft tissue sarcoma. Curr Oncol Rep. 2005 Jul; 7(4):300-6. PMID: 15946590.
      View in: PubMed
    82. Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS. Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep. 2005 Jul; 7(4):293-9. PMID: 15946589.
      View in: PubMed
    83. Steinert DM, Patel SR. Recent studies in novel therapy for metastatic sarcomas. Hematol Oncol Clin North Am. 2005 Jun; 19(3):573-90, viii. PMID: 15939198.
      View in: PubMed
    84. Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005 Sep; 20(9):1562-8. PMID: 16059628.
      View in: PubMed
    85. Hartmann JT, Patel S. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma. Drugs. 2005; 65(2):167-78. PMID: 15631540.
      View in: PubMed
    86. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 1; 64(17):5913-9. PMID: 15342366.
      View in: PubMed
    87. Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80. PMID: 15310783.
      View in: PubMed
    88. Patel SR, Papadopolous N, Raymond AK, Donato M, Seong CM, Yasko AW, Lewis VO, Lin PP, Champlin R, Benjamin RS. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis. Cancer. 2004 Jul 1; 101(1):156-63. PMID: 15222001.
      View in: PubMed
    89. Patel SR. Classification of clear-cell sarcoma. Curr Oncol Rep. 2004 Jul; 6(4):307. PMID: 15161585.
      View in: PubMed
    90. Patel SR. Molecular testing for synovial sarcoma. Curr Oncol Rep. 2004 Jul; 6(4):308. PMID: 15161586.
      View in: PubMed
    91. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 1; 58(5):1461-7. PMID: 15050324.
      View in: PubMed
    92. Trent JC, Beach J, Burgess MA, Papadopolous N, Chen LL, Benjamin RS, Patel SR. A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer. 2003 Dec 15; 98(12):2693-9. PMID: 14669291.
      View in: PubMed
    93. Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg. 2003 Dec; 186(6):665-9. PMID: 14672776.
      View in: PubMed
    94. Phan A, Patel S. Advances in neoadjuvant chemotherapy in soft tissue sarcomas. Curr Treat Options Oncol. 2003 Dec; 4(6):433-9. PMID: 14585224.
      View in: PubMed
    95. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 1; 57(3):739-47. PMID: 14529779.
      View in: PubMed
    96. Vadhan-Raj S, Patel S, Bueso-Ramos C, Folloder J, Papadopolous N, Burgess A, Broemeling LD, Broxmeyer HE, Benjamin RS. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia. J Clin Oncol. 2003 Aug 15; 21(16):3158-67. PMID: 12915607.
      View in: PubMed
    97. Pisters PW, Ballo MT, Fenstermacher MJ, Feig BW, Hunt KK, Raymond KA, Burgess MA, Zagars GK, Pollock RE, Benjamin RS, Patel SR. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7. PMID: 12915599.
      View in: PubMed
    98. Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer. Clin Cancer Res. 2003 Jul; 9(7):2426-34. PMID: 12855614.
      View in: PubMed
    99. Patel SR. Early results from randomized phase III trial of imatinib mesylate for gastrointestinal stromal tumors. Curr Oncol Rep. 2003 Jul; 5(4):273. PMID: 12781067.
      View in: PubMed
    100. Patel SR, Beach J, Papadopoulos N, Burgess MA, Trent J, Jenkins J, Benjamin RS. Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas. Cancer. 2003 Jun 1; 97(11):2848-52. PMID: 12767099.
      View in: PubMed
    101. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003 Jun 1; 56(2):482-8. PMID: 12738324.
      View in: PubMed
    102. Patel SR, Zagars GK, Pisters PW. The follow-up of adult soft-tissue sarcomas. Semin Oncol. 2003 Jun; 30(3):413-6. PMID: 12870143.
      View in: PubMed
    103. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003 May 15; 97(10):2544-53. PMID: 12733154.
      View in: PubMed
    104. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003 May 15; 97(10):2530-43. PMID: 12733153.
      View in: PubMed
    105. Patel SR. Recent advances in systemic therapy of soft tissue sarcomas. Expert Rev Anticancer Ther. 2003 Apr; 3(2):179-84. PMID: 12722877.
      View in: PubMed
    106. Patel SR. Developing therapeutic pharmaceuticals for the treatment of soft-tissue sarcomas. Expert Opin Investig Drugs. 2002 Dec; 11(12):1789-93. PMID: 12457438.
      View in: PubMed
    107. Cormier JN, Patel SR, Pisters PW. Gastrointestinal stromal tumors: rationale for surgical adjuvant trials with imatinib. Curr Oncol Rep. 2002 Nov; 4(6):504-9. PMID: 12354363.
      View in: PubMed
    108. Meric F, Hess KR, Varma DG, Hunt KK, Pisters PW, Milas KM, Patel SR, Benjamin RS, Plager C, Papadopoulos NE, Burgess MA, Pollock RE, Feig BW. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer. 2002 Sep 1; 95(5):1120-6. PMID: 12209699.
      View in: PubMed
    109. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS, Benjamin RS. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002 Jul 15; 95(2):377-88. PMID: 12124838.
      View in: PubMed
    110. Pisters PW, Ballo MT, Patel SR. Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol. 2002 Jul; 9(6):535-42. PMID: 12095968.
      View in: PubMed
    111. Patel SR. Systemic therapy for advanced soft-tissue sarcomas. Curr Oncol Rep. 2002 Jul; 4(4):299-304. PMID: 12044239.
      View in: PubMed
    112. Bilimoria MM, Holtz DJ, Mirza NQ, Feig BW, Pisters PW, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KK. Tumor volume as a prognostic factor for sarcomatosis. Cancer. 2002 May 1; 94(9):2441-6. PMID: 12015769.
      View in: PubMed
    113. Ahmad SA, Patel SR, Ballo MT, Baker TP, Yasko AW, Wang X, Feig BW, Hunt KK, Lin PP, Weber KL, Chen LL, Zagars GK, Pollock RE, Benjamin RS, Pisters PW. Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002 Jan 15; 20(2):521-7. PMID: 11786582.
      View in: PubMed
    114. Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer. 2002 Jan 1; 94(1):197-204. PMID: 11815977.
      View in: PubMed
    115. Ballo MT, Zagars GK, Pisters PW, Feig BW, Patel SR, von Eschenbach AC. Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct; 166(4):1306-10. PMID: 11547063.
      View in: PubMed
    116. Callister MD, Ballo MT, Pisters PW, Patel SR, Feig BW, Pollock RE, Benjamin RS, Zagars GK. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 1; 51(2):384-91. PMID: 11567812.
      View in: PubMed
    117. Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PW. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5. PMID: 11745234.
      View in: PubMed
    118. Patel SR, Jenkins J, Papadopolous N, Burgess MA, Plager C, Gutterman J, Benjamin RS. Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas. Cancer. 2001 Sep 1; 92(5):1347-8. PMID: 11571751.
      View in: PubMed
    119. Socinski MA, Rosenman JG, Halle J, Schell MJ, Lin Y, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial. Cancer. 2001 Sep 1; 92(5):1213-23. PMID: 11571735.
      View in: PubMed
    120. Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer. 2001 Aug 15; 92(4):863-8. PMID: 11550159.
      View in: PubMed
    121. Patel SR, Gandhi V, Jenkins J, Papadopolous N, Burgess MA, Plager C, Plunkett W, Benjamin RS. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol. 2001 Aug 1; 19(15):3483-9. PMID: 11481354.
      View in: PubMed
    122. Portera CA, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, Yasko AW, Benjamin RS, Pollock RE, Pisters PW. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001 Feb 1; 91(3):585-91. PMID: 11169942.
      View in: PubMed
    123. Eisenburg BL, Alektiar K, Ballo M, DeLaney TF, Ettinger D, Harmon D, Harris J, Joyce M, Kraybill WG, Leider S, Lucas D, Peterson I, Pollock RE, Pritchard D, Schwartz HS, Yasko AW, Pisters PT, Patel SR, watson J. Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):53-5. PMID: 11641015.
      View in: PubMed
    124. Meric F, Milas M, Hunt KK, Hess KR, Pisters PW, Hildebrandt G, Patel SR, Benjamin RS, Plager C, Papadopolous NE, Burgess MA, Pollock RE, Feig BW. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol. 2000 Oct 1; 18(19):3378-83. PMID: 11013278.
      View in: PubMed
    125. Patel SR, Benjamin RS. Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors. Surg Oncol. 2000 Aug; 9(2):67-70. PMID: 11094325.
      View in: PubMed
    126. Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol. 2000 Aug; 1(3):258-61. PMID: 12057168.
      View in: PubMed
    127. Patel SR. New agents in the treatment of soft-tissue sarcomas. Expert Opin Investig Drugs. 2000 Jul; 9(7):1545-51. PMID: 11060759.
      View in: PubMed
    128. Valenzuela RF, Kim EE, Seo JG, Patel S, Yasko AW. A revisit of MRI analysis for synovial sarcoma. Clin Imaging. 2000 Jul-Aug; 24(4):231-5. PMID: 11274890.
      View in: PubMed
    129. Spillane A, Thomas JM, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Misconceptions with staging of soft tissue sarcoma. J Clin Oncol. 2000 Apr; 18(8):1800-1. PMID: 10764441.
      View in: PubMed
    130. Fleming JB, Berman RS, Cheng SC, Chen NP, Hunt KK, Feig BW, Respondek PM, Yasko AW, Pollack A, Patel SR, Burgess MA, Papadopoulos NE, Plager C, Zagars G, Benjamin RS, Pollock RE, Pisters PW. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80. PMID: 10561352.
      View in: PubMed
    131. Patel SR, Benjamin RS. New chemotherapeutic strategies for soft tissue sarcomas. Semin Surg Oncol. 1999 Jul-Aug; 17(1):47-51. PMID: 10402637.
      View in: PubMed
    132. Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999 Jan 1; 85(1):85-92. PMID: 9921978.
      View in: PubMed
    133. Patel SR, Vadhan-Raj S, Burgess MA, Plager C, Papadopolous N, Jenkins J, Benjamin RS. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol. 1998 Jun; 21(3):317-21. PMID: 9626808.
      View in: PubMed
    134. Patel SR, Burgess MA, Papadopolous NE, Sidhu G, Gray R, Plager C, Jenkins J, Benjamin RS. Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas. Invest New Drugs. 1998; 16(1):87-92. PMID: 9740549.
      View in: PubMed
    135. Pisters PW, Patel SR, Varma DG, Cheng SC, Chen NP, Nguyen HT, Feig BW, Pollack A, Pollock RE, Benjamin RS. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution. J Clin Oncol. 1997 Dec; 15(12):3481-7. PMID: 9396401.
      View in: PubMed
    136. Worth LL, Jaffe N, Benjamin RS, Papadopoulos NE, Patel S, Raymond AK, Jia SF, Rodriguez C, Gano J, Gianan MA, Kleinerman ES. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Clin Cancer Res. 1997 Oct; 3(10):1721-9. PMID: 9815556.
      View in: PubMed
    137. Patel SR, Vadhan-Raj S, Papadopolous N, Plager C, Burgess MA, Hays C, Benjamin RS. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol. 1997 Jun; 15(6):2378-84. PMID: 9196153.
      View in: PubMed
    138. Vadhan-Raj S, Murray LJ, Bueso-Ramos C, Patel S, Reddy SP, Hoots WK, Johnston T, Papadopolous NE, Hittelman WN, Johnston DA, Yang TA, Paton VE, Cohen RL, Hellmann SD, Benjamin RS, Broxmeyer HE. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med. 1997 May 1; 126(9):673-81. PMID: 9139552.
      View in: PubMed
    139. Patel SR, Linke KA, Burgess MA, Papadopoulos NE, Plager C, Jenkins J, Benjamin R. Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas. Sarcoma. 1997; 1(2):95-7. PMID: 18521208.
      View in: PubMed
    140. Roth JA, Beech DJ, Putnam JB, Pollock RE, Patel SR, Fidler IJ, Benjamin RS. Treatment of the patient with lung metastases. Curr Probl Surg. 1996 Nov; 33(11):881-952. PMID: 8909328.
      View in: PubMed
    141. Claxton D, Xie QS, Patel S, Deisseroth AB, Kornblau S. The gene product of CBFB-MYH11. Leukemia. 1996 Sep; 10(9):1479-85. PMID: 8751466.
      View in: PubMed
    142. Patel SR, Papadopoulos NE, Plager C, Linke KA, Moseley SH, Spirindonidis CH, Benjamin R. Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants. Cancer. 1996 Aug 15; 78(4):741-4. PMID: 8756366.
      View in: PubMed
    143. Patel SR, Benjamin RS. Ifosfamide in sarcomas: is it a schedule-dependent drug? Cancer Invest. 1996; 14(3):290-1. PMID: 8630693.
      View in: PubMed
    144. Patel SR, Plager C, Papadopoulos NE, Benjamin RS. Myxoid malignant fibrous histiocytoma: experience with chemotherapy. Am J Clin Oncol. 1995 Dec; 18(6):528-31. PMID: 8526198.
      View in: PubMed
    145. Patel SR, Winchester DJ, Benjamin RS. A 15-year experience with chemotherapy of patients with paraganglioma. Cancer. 1995 Oct 15; 76(8):1476-80. PMID: 8620426.
      View in: PubMed
    146. Del Giglio A, Drach J, Kornblau SM, Patel S, Novaes M, Khetan R, Sawaya N, Dorlhiac-Llacer P, Chamone DF, Andreeff M, et al. Quantitative expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induction in patients with acute myelogenous leukemia. Leuk Lymphoma. 1995 Oct; 19(3-4):235-41. PMID: 8535214.
      View in: PubMed
    147. Vadhan-Raj S, Broxmeyer HE, Andreeff M, Bandres JC, Buescher ES, Benjamin RS, Papadopoulos NE, Burgess A, Patel S, Plager C, Hittelman WN, McAlister I, Garrison L, Williams DE. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study. Blood. 1995 Sep 15; 86(6):2098-105. PMID: 7662957.
      View in: PubMed
    148. Patel SR, Benjamin RS. Primary extraskeletal osteosarcoma--experience with chemotherapy. J Natl Cancer Inst. 1995 Sep 6; 87(17):1331-3. PMID: 7658488.
      View in: PubMed
    149. Jaffe N, Patel SR, Benjamin RS. Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation. Hematol Oncol Clin North Am. 1995 Aug; 9(4):825-40. PMID: 7490244.
      View in: PubMed
    150. Patel SR, Burgess MA, Papadopoulos NE, Linke KA, Benjamin RS. Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy. Am J Clin Oncol. 1995 Apr; 18(2):161-3. PMID: 7900708.
      View in: PubMed
    151. Patel SR, Burgess MA, Plager C, Papadopoulos NE, Linke KA, Benjamin RS. Myxoid liposarcoma. Experience with chemotherapy. Cancer. 1994 Aug 15; 74(4):1265-9. PMID: 8055448.
      View in: PubMed
    152. Vadhan-Raj S, Papadopoulos NE, Burgess MA, Linke KA, Patel SR, Hays C, Arcenas A, Plager C, Kudelka AP, Hittelman WN, et al. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J Clin Oncol. 1994 Apr; 12(4):715-24. PMID: 8151315.
      View in: PubMed
    153. Lynch HT, Fitzgibbons R, Chong S, Cavalieri J, Lynch J, Wallace F, Patel S. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum. 1994 Mar; 37(3):260-7. PMID: 8137673.
      View in: PubMed
    154. Patel SR, Forman AD, Benjamin RS. High-dose ifosfamide-induced exacerbation of peripheral neuropathy. J Natl Cancer Inst. 1994 Feb 16; 86(4):305-6. PMID: 8158686.
      View in: PubMed
    155. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1994 Jan; 22(1):100-2. PMID: 7506671.
      View in: PubMed
    156. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer. 1993 Dec 1; 72(11):3244-7. PMID: 8242548.
      View in: PubMed
    157. Benjamin RS, Legha SS, Patel SR, Nicaise C. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience. Cancer Chemother Pharmacol. 1993; 31 Suppl 2:S174-9. PMID: 8453693.
      View in: PubMed
    158. Patel S, Benjamin RS. Standard and high dose chemotherapy for advanced soft tissue sarcomas. Ann Oncol. 1992 Apr; 3 Suppl 2:S81-3. PMID: 1622875.
      View in: PubMed
    159. Benjamin RS, Chawla SP, Carrasco CH, Raymond AK, Murray JA, Armen T, Patel S, Wallace S, Ayala A, Papadopoulos NE, et al. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. Ann Oncol. 1992 Apr; 3 Suppl 2:S3-6. PMID: 1622860.
      View in: PubMed
    160. Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE. Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer. 1992 Mar 15; 69(6):1440-4. PMID: 1540881.
      View in: PubMed
    161. Patel SR, Buckner JC, Smithson WA, Scheithauer BW, Groover RV. Cisplatin-based chemotherapy in primary central nervous system germ cell tumors. J Neurooncol. 1992 Jan; 12(1):47-52. PMID: 1541978.
      View in: PubMed
    162. Patel SR, Kvols LK, Rubin J, O'Connell MJ, Edmonson JH, Ames MM, Kovach JS. Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma. Invest New Drugs. 1991 Feb; 9(1):53-7. PMID: 1709152.
      View in: PubMed
    163. Patel SR, Richardson RL, Kvols L, Zincke H. Observation after orchiectomy in clinical stage I nonseminomatous germ cell tumor of testis. Mayo Clinic experience. Am J Clin Oncol. 1990 Oct; 13(5):379-81. PMID: 2171316.
      View in: PubMed
    164. Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH. Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer. 1990 Sep 15; 66(6):1091-4. PMID: 2400962.
      View in: PubMed
    165. Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer. 1990 Aug 15; 66(4):655-8. PMID: 2201425.
      View in: PubMed
    166. Patel SR, Kvols LK, Richardson RL. Familial testicular cancer: report of six cases and review of the literature. Mayo Clin Proc. 1990 Jun; 65(6):804-8. PMID: 2195242.
      View in: PubMed
    167. Patel SR, Richardson RL, Kvols L. Synchronous and metachronous bilateral testicular tumors. Mayo Clinic experience. Cancer. 1990 Jan 1; 65(1):1-4. PMID: 2293856.
      View in: PubMed
    168. Patel SR, Kvols LK, Peterson DA, Gilbertson DT, Moertel CG, O'Dorisio TM. Comparison of the pharmacokinetics of octreotide injected at two subcutaneous sites. J Natl Cancer Inst. 1989 Dec 20; 81(24):1926-9. PMID: 2593172.
      View in: PubMed
    169. Patel SR, Richardson RL, Kvols L. Metastatic cancer to the testes: a report of 20 cases and review of the literature. J Urol. 1989 Oct; 142(4):1003-5. PMID: 2677407.
      View in: PubMed
    170. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer.
    171. Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma?. Journal of Computer Assisted Tomography.
    172. Antitumor response of VEGFR2- and VEGFR3-amplified angiosarcoma to pazopanib. JNCCN Journal of the National Comprehensive Cancer Network. 14:499-502.
    173. Soft tissue sarcomas. 311-318.
    174. Benign Tumours of the Spine. Spine.
    175. Treatment of recurrent soft tissue sarcoma. Problems in General Surgery. 16:73-83.
    176. Chemotherapy for soft-tissue sarcomas. ONCOLOGY (United States). 29.
    177. Cancer Chemotherapy and Pharmacology. Cancer Chemotherapy and Pharmacology. 67.
    178. Soft Tissue Sarcomas. 696-703.
    179. Assessment of the tumour viability by diffusion-weighted MR imaging. Clinical MRI. 11:75-78.
    180. An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients. Current Oncology Reports. 18.
    181. Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney. American Journal of Clinical Oncology: Cancer Clinical Trials.
    182. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. 7:64421-64430.
    183. Erratum. Current Oncology Reports. 14:220.
    184. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?. Clinical Orthopaedics and Related Research. 473:3604-3611.
    185. Survival of patients with metastatic leiomyosarcoma. Cancer Medicine. 5:3437-3444.
    186. Clinical Decision Making. Spine.
    187. Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. Oncotarget. 7:67521-67531.
    188. STUMP un"stumped". Journal of Hematology and Oncology. 8.
    189. Assessing the role of 18F-FDG PET and 18F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies. European Journal of Nuclear Medicine and Molecular Imaging. 1-11.
    190. Primary retroperitoneal tumors. 403-421.
    191. Assessment of imaging modalities and response metrics in Ewing sarcoma. Journal of Clinical Oncology. 34:3680-3685.
    192. Chemotherapy for bone sarcoma in adults. Journal of Oncology Practice. 12:208-216.
    193. Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer. Journal of Clinical Neuroscience. 34:15-22.
    194. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Scientific Reports. 6.
    195. SARC009. Cancer. 122:868-874.
    196. Adult versus pediatric neuroblastoma. Sarcoma. 2014.
    PATEL's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description